scholarly journals Prescribing in pregnancy

2008 ◽  
Vol 192 (5) ◽  
pp. 321-322 ◽  
Author(s):  
Carol Paton
Keyword(s):  
Mental Illness ◽  
Pregnant Woman ◽  
Psychotropic Drugs ◽  
Treatment Plan ◽  
Morbidity And Mortality ◽  
Maternal Mental Illness ◽  
In Pregnancy

SummaryPsychotropic drugs reduce morbidity and mortality related to maternal mental illness but may also cause harm to the foetus, the nature and magnitude of which is not completely understood. Up-to-date information should be shared as fully as possible with the pregnant woman and a treatment plan agreed jointly.

Peripartum psychiatric disorders

2016 ◽  
Author(s):  
Roch Cantwell
Keyword(s):  
Mental Illness ◽  
Adverse Effects ◽  
Infant Development ◽  
Social Challenges ◽  
The United Kingdom ◽  
Maternal Mental Illness ◽  
Changes In Pregnancy ◽  
Risk Reducing ◽  
Careful Management ◽  
In Pregnancy

Women are at greatest risk of suffering from mental illness during their reproductive years, and at very particular risk in relation to childbirth. Psychological adjustment, social challenges, and neurohormonal changes in pregnancy and parturition may all contribute to this risk. The consequences of maternal mental illness may be severe. Suicide is among the leading causes of maternal death in the United Kingdom and psychiatric factors are implicated in a further significant number of deaths in pregnancy and the first postnatal year. Increasing evidence points to the detrimental effect of untreated maternal anxiety and depression on infant development. Women may be taking psychotropic medication at conception, with antidepressants being one of the most frequently prescribed. Certain psychotropics have important adverse effects on the fetus and developing child, and may require careful management if prescribed in pregnancy. All professionals involved in the care of women at this time have an important role in identifying those at risk, reducing progression to future morbidity and mortality, and minimizing the adverse effects of prescribed medication.

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

2005 ◽  
Vol 7 (2) ◽  
pp. 111-124 ◽  
Author(s):  
Vera Hassner Sharav
Keyword(s):  
Mental Illness ◽  
Psychotropic Drugs ◽  
Treatment Plan ◽  
Medication Treatment ◽  
Faith Based ◽  
United States Population ◽  
Behavioral Abnormalities ◽  
Children First ◽  
And Behavior ◽  
The Impact

The implementation of a recommendation by the President’s New Freedom Commission (NFC) to screen the entire United States population—children first—for presumed, undetected, mental illness is an ill-conceived policy destined for disastrous consequences. The “pseudoscientific” methods used to screen for mental and behavioral abnormalities are a legacy from the discredited ideology of eugenics. Both eugenics and psychiatry suffer from a common philosophical fallacy that undermines the validity of their theories and prescriptions. Both are wed to a faith-based ideological assumption that mental and behavior manifestations are biologically determined, and are, therefore, ameliorated by biological interventions. NFC promoted the Texas Medication Algorithm Project (TMAP) as a “model” medication treatment plan. The impact of TMAP is evident in the skyrocketing increase in psychotropic drug prescriptions for children and adults, and in the disproportionate expenditure for psychotropic drugs. The New Freedom Commission’s screening for mental illness initiative is, therefore, but the first step toward prescribing drugs. The escalating expenditure for psychotropic drugs since TMAP leaves little doubt about who the beneficiaries of TMAP are. Screening for mental illness will increase their use.

scholarly journals Púrpura trombocitopénica trombótica versus síndrome HELLP: reto diagnóstico en el embarazo.

2021 ◽  
Vol 81 (03) ◽  
pp. 292-296
Author(s):  
Leidy De Jesus Henriques ◽  
Katherine Rosales Pereira ◽  
Diana De Oliveira-Gomes ◽  
Rocío Iglesias Fortes ◽  
Erick Dávila Alcalá
Keyword(s):  
Pregnant Woman ◽  
Hellp Syndrome ◽  
Clinical Spectrum ◽  
Morbidity And Mortality ◽  
Diagnostic Challenge ◽  
Appropriate Treatment ◽  
Hematological Alterations ◽  
In Pregnancy

Worldwide, thrombocytopenia is one of the first causes of hematological alterations in pregnancy, affecting up to 10% of them. Despite the fact that all clinical entities with thrombocytopenia in pregnancy have a similar clinical spectrum, the distinction between them is vital to establish the appropriate treatment and thus reduce maternal-fetal morbidity and mortality. Purpura thrombotic thrombocytopenic is an infrequent disease, which despite not being linked to pregnancy, is not exempt from occurring in it, compared to HELLP syndrome, which is a multisystemic complication that occurs during pregnancy. The following is the case of a pregnant woman with microangiopathic thrombocytopenic anemia where the clinical similarity of both pathologies is evidenced, representing a diagnostic challenge. Keywords: Thrombocytopenia, Pregnancy, HELLP Syndrome, Purpura thrombotic thrombocytopenic, Anemia.

The Rational Use of Psychotropic Drugs in Pregnancy and Postpartum

1986 ◽  
Vol 31 (3) ◽  
pp. 183-190 ◽  
Author(s):  
Gail Erlick Robinson ◽  
Donna E. Stewart ◽  
Edred Flak
Keyword(s):  
Pregnant Woman ◽  
Psychotropic Medication ◽  
Psychotropic Drugs ◽  
Teratogenic Effects ◽  
Rational Use ◽  
Nursing Mother ◽  
Pregnancy And Postpartum ◽  
Withdrawal Effects ◽  
Breast Fed ◽  
In Pregnancy

When a pregnant woman or nursing mother requires psychotropic medication, one must consider the effect of such medications on the fetus or baby. The authors review the evidence for teratogenic effects of such drugs given during pregnancy, toxic or withdrawal effects in the newborn and dangers to the breast-fed baby. Suggestions are made for judicious use of psychotropic drugs in pregnant or nursing women.

scholarly journals 31. Influenza Vaccination During Pregnancy: A Descriptive Cross-sectional Survey of the Knowledge, Beliefs, and Attitudes of Mexican Gynecologists and Family Physicians

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S39-S39
Author(s):  
Erika Z Lopatynsky-Reyes ◽  
Sue Ann Costa-Clemens ◽  
Enrique Chacon-Cruz ◽  
Michael Greenberg
Keyword(s):  
Influenza Vaccination ◽  
Pregnant Women ◽  
Latin American ◽  
Vaccine Coverage ◽  
Family Physicians ◽  
Morbidity And Mortality ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Beliefs And Attitudes ◽  
In Pregnancy

Abstract Background Influenza in pregnancy is associated with elevated morbidity and mortality. Influenza vaccines are both safe and effective in pregnancy, supporting routine use in this population. Even though influenza vaccination in Mexico is recommended for pregnant women, there are no publications of influenza vaccine coverage in pregnancy. This is the first Latin American survey done only in physicians aiming to assess the knowledge, beliefs, and attitudes that Mexican Obstetrics-Gynecologists (OBG) and Family Physicians (FP) have towards influenza and influenza immunization during pregnancy. Methods A cross-sectional survey was conducted, both paper-based and online. The questionnaire was composed of 35 questions, which addressed general knowledge of influenza, recommendations for vaccination during pregnancy, and beliefs and attitudes concerning the acceptability of the vaccine in pregnant women. Results A total of 206 completed surveys were available, 98 (47.6%) from OBG, 108 (52.4%) from FP. Regarding current practicing medical institutions, 76 (37%), 69 (34%), 31 (14.5%), 30 (14.5%) reported working for the Mexican Institute of Social Security, Private Sector, Secretariat of Health, or a combination of all respectively, representing an estimated 2,472 daily pregnancy consultations. About a quarter (26.2%) reported not having a notion that influenza is more severe among pregnant women. More than half (51.5%) ignored the potential side effects of influenza infection on the fetus. The majority (56.8%) did not know when vaccination during pregnancy should occur. Pregnancy as a risk factor for developing influenza complications was known only in 48.1%. Also, 46.1 % believed that vaccination only confers protection to the mother, but not to the fetus. Nevertheless, 96.1% considered that immunization against influenza during pregnancy is a safe and effective preventive intervention. A results’ summary is shown in Figure-1. Conclusion Based on this survey, current knowledge of OBG and FP for influenza morbidity and mortality during pregnancy, and the importance of influenza vaccination in pregnant women, is poor. Mandatory recommendations to educate medical providers regarding influenza vaccination during pregnancy in Mexico are necessary, even as imperative for CME credits. Disclosures All Authors: No reported disclosures

Research in pregnancy and mental illness: testing old wives' hypotheses

1993 ◽  
Vol 14 (3) ◽  
pp. 163-183 ◽  
Author(s):  
P. Krener ◽  
J. N. Treat ◽  
R. L. Hansen
Keyword(s):  
Mental Illness ◽  
In Pregnancy

Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases

2004 ◽  
Vol 24 (7) ◽  
pp. 513-518 ◽  
Author(s):  
Martin Enders ◽  
Andrea Weidner ◽  
Iris Zoellner ◽  
Karen Searle ◽  
Gisela Enders
Keyword(s):  
Parvovirus B19 ◽  
Morbidity And Mortality ◽  
Human Parvovirus B19 ◽  
Prospective Evaluation ◽  
Parvovirus B19 Infection ◽  
In Pregnancy

From Rogers to Rivers: The Rights of the Mentally Ill to Refuse Medication

1987 ◽  
Vol 13 (1) ◽  
pp. 7-52
Author(s):  
Ellen Wright Clayton
Keyword(s):  
Mental Illness ◽  
Psychotropic Drugs ◽  
Mentally Ill ◽  
United States Supreme Court ◽  
Federal Courts ◽  
State Courts ◽  
Court Decisions ◽  
Marked Contrast ◽  
Patients Rights ◽  
Treatment Refusals

AbstractMany individuals with mental illness wish to avoid psychotropic drugs, a type of treatment that may relieve their symptoms only at the risk of unpleasant, even permanent, side effects. In marked contrast to the widely-held view that most patients may refuse any treatment and that even patients with mental illness may reject other psychoactive interventions such as electroconvulsive therapy and psychosurgery, the courts and legislatures have been slow to recognize any right to refuse psychotropic drugs. This Article demonstrates that many of the justifications offered for forcing patients to take unwanted medications are inadequate and that unless treatment refusals are reviewed outside mental institutions, patients’ rights will rarely receive appropriate deference. The author analyzes the federal and state litigation to determine whether the courts have fashioned meaningful relief for the mentally ill. The Article concludes that two recent United States Supreme Court decisions have made it impossible for the federal courts to provide adequate protection. By contrast, several state courts have responded to the needs and rights of patients with mental illness.

Sign in / Sign up

Export Citation Format

Share Document